Ponce Therapeutics Inc

Ponce Therapeutics Inc. is a United States-based biotechnology company headquartered in Florida. Founded by a team of experienced scientists and entrepreneurs, the company currently employs 8 individuals and generates an annual revenue of $2.5 million. Ponce Therapeutics is dedicated to developing innovative therapeutic solutions for the aging process. The company focuses on leveraging advanced biotechnology platforms to create novel senolytic and senomorphic therapies. These targeted treatments aim to restore the balance between young and aged, or "senescent," cells within the body, particularly in the skin. By selectively eliminating senescent cells and promoting the function of healthy cells, Ponce Therapeutics seeks to mitigate the effects of aging and enhance skin rejuvenation. Ponce Therapeutics utilizes proprietary technology to discover and develop these groundbreaking therapies. Their approach involves identifying and targeting the fundamental mechanisms of cellular aging, aiming to reverse the biological clock and restore youthful vitality. The company's senolytic and senomorphic therapies offer a unique approach to addressing the challenges associated with aging, potentially leading to significant improvements in skin health and overall well-being. For more information about Ponce Therapeutics Inc. and its innovative therapies, you can visit their website at poncetherapeutics.com.